When Sunthar Vykunthanathan started stand-up comedy about eight years ago, he performed mostly in English. But he decided to switch it up when he noticed a big portion of his audience was Tamil. “The ...
A 32-year-old woman from Tamil Nadu died days after her family allegedly attempted to deliver her baby at home by following YouTube videos instead of taking her to a hospital, raising fresh concerns ...
Security tools are written in specific languages for reasons, not by accident. Python runs most pen-test automation. Metasploit is Ruby. Ghidra and IDA output x86 Assembly. CISA and the NSA are now ...
Video shows TN minister crushing white powder at IPL match Minister says he was crushing medicine for his sick daughter Clip sparks drug use allegations and calls for resignation Tamil Nadu Minister ...
White House officials on Tuesday shot down a report speculating President Trump gained access to the retatrutide weight loss drug under the Food and Drug Administration’s (FDA) “compassionate use ...
US President Donald Trump speaks to the press after stepping off Air Force One at Reading Regional Airport on June 23, 2026. Eli Lilly and the Food and Drug Administration allowed a person to have ...
The White House has denied that President Donald Trump was given an experimental new obesity drug through the Food and Drug Administration’s (FDA) “compassionate use” program. Trump, 80, became the ...
A special 79-year-old man has received unparalleled access to Eli Lilly's obesity drug. Millions of Americans are eagerly awaiting access to retatrutide, a powerful new drug from the pharmaceutical ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The White House has denied that President Donald Trump was given an ...
The FDA has collaborated with Eli Lilly (LLY) to allow an unidentified 79-year-old man to receive the Indiana-based pharma giant’s next-gen obesity therapy retatrutide, Stat News reported on Tuesday.
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...